The Kinghorn Cancer Centre

Recent papers from The Kinghorn Cancer Centre

1. Incretin-Based Therapies in Prostate Cancer: From Metabolic Protection to Potential Antitumour Activity - A Narrative ReviewEndocrine Related Cancer · 2026
2. Genetic variants shape single-cell chromatin accessibility and disease riskNature · 2026
3. An Australian Narrative Review of Adoptive Cellular Therapies in Malignancy: Expanding Indications, Referral Pathways and Safety Beyond Specialist CentresThe Medical Journal of Australia · 2026
4. Neurokinin-3 Receptor Antagonism for Refractory Hot Flashes in MenNew England Journal of Medicine · 2025
5. Designing for delivery: a Delphi study of feasibility-informed implementation strategies for a fear of cancer recurrence clinical pathwaySupportive Care in Cancer · 2026
6. Patient perspectives on cardioprotective medication during breast cancer treatmentCardio-Oncology · 2026
7. Selinexor plus lenalidomide versus lenalidomide alone as maintenance therapy after autologous haematopoietic stem cell transplantation in newly diagnosed multiple myeloma: Results of the phase 3 ALLG MM23 ( SeaLAND ) trialBritish Journal of Haematology · 2026
8. Tumour-agnostic immunotherapy: aligning biological rationale, biomarker precision, and real-world implementationEClinicalMedicine · 2026
9. TERT Reactivation in Thyroid Cancer: Mechanisms, Clinical Implications, and Therapeutic OpportunitiesEuropean Thyroid Journal · 2026
10. Tumor-Intrinsic Blood and Imaging Correlatives in Advanced Prostate Cancer Treated with Combination Radiopharmaceutical Therapy and ImmunotherapyJournal of Nuclear Medicine · 2026
11. Oxygen-dependent subcellular redistribution of PHD3 links the hypoxic microenvironment to mitochondrial metabolic reprogramming in ccRCCExperimental & Molecular Medicine · 2026
12. Advancing Homologous Recombination Repair Mutation Testing in Prostate Cancer in Australia: Shifting the Focus to Hormone Sensitive Prostate CancerAsia-Pacific Journal of Clinical Oncology · 2026
13. Post-prostatectomy magnetic resonance-guided adaptive salvage radiotherapy: early toxicity and biochemical outcomes from a prospective single center cohortClinical and Translational Radiation Oncology · 2026
14. A randomized pilot trial comparing anti-thymocyte globulin with anti-thymocyte globulin plus post transplant cyclophosphamide for prophylaxis against acute and chronic graft versus host disease in matched donor hematopoietic cell transplants – a study from the Cell Therapy Transplant Canada/ Australasian Leukemia Lymphoma Group ConsortiumBone Marrow Transplantation · 2026
15. Patient-derived models of prostate cancer: Capturing tumour complexity from initiation to metastasisCancer Letters · 2026
16. Impact of socioeconomic status on treatment and survival in multiple myeloma in AustraliaBlood Cancer Journal · 2026
17. Pembrolizumab and Denosumab in Clear-Cell Renal-Cell Carcinoma.2026
18. A Phase 2, Open-Label, Randomized Controlled Trial Evaluating Safety and Efficacy of Dose-Intensified Versus Standard Dosing Regimens of [ ¹⁷⁷ Lu]Lu-PSMA-597 in mCRPC (OPTIMAL-PSMA)Journal of Nuclear Medicine · 2026
19. Aggressive pituitary neuroendocrine tumours display a distinct immune microenvironmentThe Journal of Clinical Endocrinology & Metabolism · 2026
20. Worldwide Innovative Network Consortium: Building a Common Global Cancer DatabaseJCO Global Oncology · 2026